WhatistheSymbol
Nordion Inc trades in the stock market under the ticker symbol of NDZ. Search for the ticker of any public company above using the 'Get Ticker' search in red.

Who is Nordion Inc?

Nordion Inc., a health science company, provides various products and services used for the prevention, diagnosis, and treatment of diseases worldwide. It involves in the processing, packaging, and delivery of medical isotopes for cardiology, oncology, and neurology. The company also supplies targeted therapies for various cancers. Its products include TheraSphere, a treatment for liver cancer; radiopharmaceutical services; medical imaging services; and manufacturing contract services, such as tailored solutions, expertise, and service capabilities for radiopharmaceutical development, clinical and commercial manufacturing, and radiation-based medical device development. In addition, the company engages in the design, construction, and maintenance of commercial gamma sterilization systems for medical devices, food irradiation, and combination products. Its product line comprises C-188 cobalt-60, double-encapsulated sources for gamma sterilization; irradiator products; and professional services, including control system upgrades, efficiency improvements, safety retrofits, dosimetry, and mathematical modeling. The company offers its products and services to pharmaceutical and biotechnology companies, medical-device manufacturers, hospitals, clinics, and research laboratories. The company was formerly known as MDS Inc. and changed its name to Nordion Inc. in November 2010. Nordion Inc. was founded in 1946 and is headquartered in Ottawa, Canada.

www.mdsnordion.com
500 Employees
Last Reported Date: 09/5/12
Founded in 1946
Last $6.51 USD
Change Today +0.03 / 0.46%
Volume 179.3K
As of 1:51 PM 11/1/12 All times are local (Market data is delayed by at least 15 minutes).

nordion inc (NDZ) Snapshot

Open
$6.54
Previous Close
$6.48
Day High
$6.59
Day Low
$6.43
52 Week High
09/7/12 - $10.96
52 Week Low
09/10/12 - $5.51
Market Cap
403.0M
Average Volume 10 Days
188.2K
EPS TTM
--
Shares Outstanding
61.9M
NDZ Does Not Pay Dividends
P/E TM
--
NDZ:US Historical Stock Quote
NDZ:US Advanced Stock Chart

nordion inc (NDZ) Latest News

NYSE stocks posting largest volume decreases
More News

nordion inc (NDZ) Related News

No Related News Found

nordion inc (NDZ) Key Developments

Nordion Inc. Restructures Russian Mo-99 Supply Relationship

Nordion Inc. announced that it has been granted special permission by The Open Joint Stock Company 'Isotope', the authorized subsidiary of Russia's State Atomic Energy Corporation 'Rosatom', to enter into a negotiation directly with the Research Institute of Atomic Reactors (RIAR) for supply of Molybdenum-99 (Mo-99). Nordion and Isotope have jointly agreed that the current Mo-99 supply agreement structure was no longer appropriate and have terminated their Mo-99 supply agreement effective Oct. 26, 2012. The 2010 framework agreement with Isotope, to explore and define areas of collaboration for the supply, marketing and sale of isotopes produced in Russia is expected to remain in effect. With confirmation that the MAPLE facilities will not be commissioned, Nordion is now reassessing sources of long-term Mo-99 supply. Nordion intends to enter a negotiation directly with RIAR for the supply of Mo-99 to potentially reach an agreement that better fits the current production capabilities and market dynamics. Similar to the Isotope supply agreement, the negotiations with RIAR are intended to focus on the supply of Mo-99 to Nordion for the processing, distribution and sale of Mo-99 outside of the Russian Federation. This supply of Mo-99 would be produced by RIAR's reactors in Dimtrovgrad, Russia. If an agreement is reached with RIAR, Nordion expects that such an agreement could establish, following required regulatory approvals, a supplemental supply of Mo-99 which could potentially meet a portion of Nordion's long-term supply requirements. The Mo-99 volume associated with supply from RIAR would be anticipated to be significantly lower compared with the original agreement that Nordion had with Isotope.

Nordion Inc. Extends Molybdenum-99 Supply Contract with Lantheus Medical Imaging, Inc. for an Additional Two Years

Nordion Inc. extended its contract with its primary Medical Isotopes customer, Lantheus Medical Imaging Inc. for the supply of Molybdenum-99 (Mo-99). Under the terms of the amended agreement, the contract has been extended for an additional two years through 2015. Nordion expects to supply Mo-99 on a weekly basis to Lantheus Medical Imaging. The multi-year contract reflects specific pricing for each year of the contract. Medical isotopes are used by physicians to diagnose and treat a number of diseases, including cardiac and neurological conditions, and several types of cancer. Mo-99, and more specifically the derivative medical isotope technetium-99m, is utilized in approximately 80% of nuclear medical procedures worldwide.

Nordion Inc. Announces Management Changes

Nordion Inc. announced the appointment of Jeff Brown, Chief Executive Officer and founding member of Brown Equity Partners, LLC, to its Board of Directors. Scott McIntosh, formerly Senior Vice-President of Operations, becomes the COO of Specialty Isotopes and will also assume the role of General Manager, Sterilization Technologies. Tom Burnett, formerly Vice-President of Global Sales becomes General Manager, Medical Isotopes, and will report into Mr. McIntosh. Chief Operating Officer, Targeted Therapies: Steve West, Chief Executive Officer of Nordion, will act as interim COO of Targeted Therapies as Nordion initiates an external search for a permanent leader. Mr. Brown previously served as a founding partner and primary deal originator and capital gains producer for Forrest Binkley & Brown. Prior to this he was Senior Vice President at Bank America Venture Capital Group and performed the same role at Security Pacific Capital Corporation. Mr. Brown has served on the Board of Directors of numerous companies during his 25 years in the investment industry.

Most Popular on

It's Global Warming, Stupid
Zuckerberg's Dorm Mate: $400M Mistake & No Regrets
Mitt Romney's Missed Opportunity
NYC Rats: Stronger Than Sandy
Why the Marathon Is the Last Thing New York Needs
More News
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NDZ:US $6.51 USD +0.03

NDZ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Accelrys Inc $9.15 USD +0.20
Eckert-Ziegler Bebig €1.82 EUR 0.00
Harvard Bioscience Inc $3.86 USD -0.16
Ion Beam Applications €6.63 EUR +0.13
Sirtex Medical Ltd A$10.95 AUD -0.05
 

Industry Analysis

NDZ

Industry Average

Valuation NDZ Industry Range
Price/Earnings 19.2x
Price/Sales 1.7x
Price/Book 1.5x
Price/Cash Flow 9.8x
TEV/Sales 1.1x
 | 

Post a JobJobs

  • Product Manager - Consumer Team
    San Francisco, CA | Yelp
    Posted: Oct 26
  • Professor in Technology Management
    Santa Barbara, CA | University of California, Santa Barbara
    Posted: Oct 03
  • Hereford, AZ | University of Arizona Health Network
    Posted: Oct 18
  • Simi Valley, CA | Simi Valley Hospital
    Posted: Oct 31
Simply Hired

Sponsored Links

Nordion shareholders back $805 mln takeover by Sterigenics

[Reuters] - Shareholders of Canadian medical isotope supplier Nordion Inc voted on Friday to support a friendly $805 million takeover offer by U.S.-based Sterigenics International, clearing a major hurdle facing the deal. More than 76 percent of votes cast by shareholders backed the offer, satisfying a requirement for two-thirds support, Nordion Chairman Bill Anderson said during the company's annual and special meeting in Ottawa. Nordion is one of the world's leading producers of molybdenum-99, an isotope used in medical imaging. To get its raw material, Nordion depends on an aging nuclear reactor run by state-owned Atomic Energy of Canada Ltd (AECL) in Chalk River, Ontario.

6 Jun 2015

Read More...
Nordion Provides Detailed Results from Annual and Special Meeting of Shareholders

[Business Wire] - Nordion Inc. today announced the detailed results from its Annual and Special Meeting of Shareholders which took place earlier today. As stated in an earlier announcement, Nordion’s shareholders have approved the special resolution authorizing the previously announced plan of arrangement providing for the acquisition of all the outstanding Nordion shares for cash consideration of US$13.00 per share ...

6 Jun 2015

Read More...
Nordion receives final court approval for acquisition by Sterigenics

11 Jun 2015

Read More...
Overview: AQR Capital Management positions in 1Q14

17 Jun 2015

Read More...
Why AQR Capital starts new position in Riverbed Technology

17 Jun 2015

Read More...
Why AQR Capital initiates new position in Nordion

18 Jun 2015

Read More...
Must-know: Why AQR Capital exits position in LyondellBasell

18 Jun 2015

Read More...
Why AQR Capital liquidates position in Marvell Technology

18 Jun 2015

Read More...
Nordion Receives Second Request Under Hart-Scott-Rodino Act

[at noodls] - OTTAWA, Ontario--(BUSINESS WIRE)--Jun. 27, 2014-- Nordion Inc. (TSX:NDN) (NYSE:NDZ) announced today that it and Sterigenics International LLC ("Sterigenics") have each received a request for ...

27 Jun 2015

Read More...
Nordion Announces Termination of Hart-Scott-Rodino Act Waiting Period and Receipt of No-Action Letter for Acquisition by Sterigenics

[Business Wire] - Nordion Inc. announced that on July 10, 2014 the Federal Trade Commission terminated the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended with respect to Sterigenics’ proposed acquisition of Nordion and the Canadian Competition Bureau issued a no-action letter pursuant to the Competition Act.

11 Jul 2015

Read More...
Subject Author Date
Hope They Get A Big MAPLE Award roboklerk 2012-10-16 21:06:38
Best Day for the Market In a Year? roboklerk 2012-10-16 21:06:14
How Many Disappointing Quarters In a Row? roboklerk 2012-10-16 21:05:55
Possible shareholder Lawsuit mhunter682 2012-10-16 21:05:24
A company to watch (and this may be a surprise to you...) dominic.lasalle 2012-10-16 21:04:54
For many Investors NDZ Was All About MAPLES roboklerk 2012-10-16 21:04:33
Better Do CC Real Quick or Halt roboklerk 2012-10-16 21:04:13
This is the HIGH of the day. SHORT SHORT SHORT is what i am doing holywallst 2012-10-16 21:04:01
Profit takers will take profits now. Enjoy the TOP while it lasts holywallst 2012-10-16 21:03:32
ADNC was drop big on friday over 65%..rebounding now.. take a look.. ushdstore 2012-10-16 21:03:17
No more dividend?... rrtzrealmd 2012-10-16 21:03:02
Seeking Alpha article lorin1826 2012-10-16 21:02:46
ADNC is rocking today after drop 69% on friday.. big day, probably going back to $10 this ... ushdstore 2012-10-16 21:02:29
Nordion did not loose 38 % of its fair value over losing a lawsuit akidwadream 2012-10-16 21:01:51
$AONE A123 Systems (AONE) Hit Volatility Trading Pause today on Massive Price Spike!! Rall... hogolddigger 2012-10-16 21:01:24
Look for Sell-Side Analysts to Rally It to 8-9 roboklerk 2012-10-16 21:01:11
I'd Guess At Least Half the Inst. Shs. Turnover roboklerk 2012-10-16 21:00:54
It Was an Absolutely Stunning Ruling roboklerk 2012-10-16 21:00:44
May get Nothing from MAPLES Arbitration? roboklerk 2012-10-16 21:00:28
On NYSE Leading % Loser List Again Today roboklerk 2012-10-16 21:00:09
When the dust clears! hotracer2012 2012-10-16 20:59:48
Nobody Is Selling - Up Side Only droczey 2012-10-16 20:59:17
Stocks In Focus NDZ estradasandoval659 2012-10-16 20:59:04
No Dividend, Likely to be Hit w/ Arb. Costs roboklerk 2012-10-16 20:58:48
Just Chipping Away 'Til Nothing Is Left roboklerk 2012-10-16 20:58:32
  • 0
  • 0
  • 0

Get our Stock Market & Financial Investment news alerts in your inbox

Read our full disclaimer and privacy policy